ROLE OF VIF IN REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CD4+ T LYMPHOCYTES

被引:373
作者
GABUZDA, DH
LAWRENCE, K
LANGHOFF, E
TERWILLIGER, E
DORFMAN, T
HASELTINE, WA
SODROSKI, J
机构
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV HUMAN RETROVIROL,44 BINNEY ST,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
关键词
D O I
10.1128/JVI.66.11.6489-6495.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The viral infectivity factor gene vif of human immunodeficiency virus type 1 has been shown to affect the infectivity but not the production of virus particles. In this study, the effect of vif in the cont"t of the HXB2 virus on virus replication in several CD4+ T-cell lines was investigated. vif was found to be required for replication in the CD4+ T-cell lines CEM and H9 as well as in peripheral blood T lymphocytes. vif was not required for replication in the SupT1, C8166, and Jurkat T-cell lines. The infectivity of vif-defective viruses depended on the cell type in which the virus was produced. In CEM cells, vif was required for production of virus capable of initiating infection in all cell lines studied. vif-defective virus produced by SupT1, C8166, and Jurkat cells and the monkey cell line COS-1 could initiate infection in multiple cell lines, including CEM and H9. These results suggest that vif can compensate for cellular factors required for production of infectious virus particles that are present in some cell lines such as SupT1, C8166, and Jurkat but are absent in others such as CEM and H9 as well as peripheral blood T lymphocytes. The effect of vif was not altered by deletion of the carboxyl terminus of gp41, a proposed target for vif (B. Guy, M. Geist, K. Dott, D. Spehner, M.-P. Kieny, and J.-P. Lecocq, J. Virol. 65:1325-1331, 1991). These studies demonstrate that vif enhances viral infectivity during virus production and also suggest that vif is likely to be important for natural infections.
引用
收藏
页码:6489 / 6495
页数:7
相关论文
共 34 条
  • [1] BIOLOGICAL CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 MUTANTS IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    AKARI, H
    SAKURAGI, J
    TAKEBE, Y
    TOMONAGA, K
    KAWAMURA, M
    FUKASAWA, M
    MIURA, T
    SHINJO, T
    HAYAMI, M
    [J]. ARCHIVES OF VIROLOGY, 1992, 123 (1-2) : 157 - 167
  • [3] SEQUENCE OF SIMIAN IMMUNODEFICIENCY VIRUS FROM MACAQUE AND ITS RELATIONSHIP TO OTHER HUMAN AND SIMIAN RETROVIRUSES
    CHAKRABARTI, L
    GUYADER, M
    ALIZON, M
    DANIEL, MD
    DESROSIERS, RC
    TIOLLAIS, P
    SONIGO, P
    [J]. NATURE, 1987, 328 (6130) : 543 - 547
  • [4] CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
  • [5] VIRAL PROTEIN-R OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AND TYPE-2 IS DISPENSABLE FOR REPLICATION AND CYTOPATHOGENICITY IN LYMPHOID-CELLS
    DEDERA, D
    HU, W
    VANDERHEYDEN, N
    RATNER, L
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (07) : 3205 - 3208
  • [6] EMMRICH F, 1991, DRUGS INFLAMMATION S, V32, P165
  • [7] THE SOR GENE OF HIV-1 IS REQUIRED FOR EFFICIENT VIRUS TRANSMISSION INVITRO
    FISHER, AG
    ENSOLI, B
    IVANOFF, L
    CHAMBERLAIN, M
    PETTEWAY, S
    RATNER, L
    GALLO, RC
    WONGSTAAL, F
    [J]. SCIENCE, 1987, 237 (4817) : 888 - 893
  • [8] FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO
  • [9] 2-J
  • [10] EFFECTS OF DELETIONS IN THE CYTOPLASMIC DOMAIN ON BIOLOGICAL FUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS
    GABUZDA, DH
    LEVER, A
    TERWILLIGER, E
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (06) : 3306 - 3315